Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors-Reference-Cited by-同舟云学术

Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors

Published:2005-04-11 Issue:31 Volume:24 Page:4993-4999
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Zhu Hongbo,Zhang Lidong,Dong Fengqin,Guo Wei,Wu Shuhong,Teraishi Fuminori,Davis John J,Chiao Paul J,Fang Bingliang

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1208683.pdf

Reference21 articles.

1. Adams J . (2002a). Oncologist, 7, 9–16.

2. Adams J . (2002b). Curr. Opin. Oncol., 14, 628–634.

3. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S and Elliott PJ . (1999). Cancer Res., 59, 2615–2622.

4. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ and Chinnadurai, G . (1995). Oncogene, 11, 1921–1928.

5. Gillissen B, Essmann F, Graupner V, Starck L, Radetzki S, Dorken B, Schulze-Osthoff K and Daniel PT . (2003). EMBO J., 22, 3580–3590.

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Experience on Proteasome Inhibitors in Cancer;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

2. RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival;International Journal of Molecular Sciences;2022-01-02

3. The efficacy and mechanism of proteasome inhibitors in solid tumor treatment;Recent Patents on Anti-Cancer Drug Discovery;2021-12-02

4. A critical transcription factor NF-κB as a cancer therapeutic target and its inhibitors as cancer treatment options;Current Medicinal Chemistry;2020-11-11

5. Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer;Current Cancer Drug Targets;2020-07-07